Company · CIK 0001867096 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Xeris Biopharma Holdings, Inc. · XERS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 1, 6:21 pm EDT | Kevin McCullochSee Remarks | 15,000 | $8.49 | $127,308 | 1,639,208 | −0.91% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:21 pm EDT | Beth HechtSee Remarks | 16,666 | $8.49 | $141,434 | 1,127,796 | −1.46% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:20 pm EDT | Steven PieperSee Remarks | 5,000 | $8.50 | $42,500 | 1,356,053 | −0.37% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.